Powered by

Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America

Jul 28, 2020 - PR Newswire

PR Newswire

Atomo has announced that it has signed a binding agreement with US-based diagnostics specialist Access Bio Inc. (KOSDAQ: 950130) (Access Bio) that will see Atomo supply its unique, integrated rapid diagnostic test (RDT) devices to Access Bio for use with its rapid test strip for detection of antibodies to COVID-19.

Finished products being commercialised under this agreement include a COVID-19 rapid antibody test for professional use, and a COVID-19 rapid antibody test for...